Salivary, serological, and cellular immune response to the CoronaVac vaccine in health care workers with or without previous COVID-19
MM Ortega, LT da Silva, ÉD Candido, Y Zheng… - Scientific Reports, 2022 - nature.com
We investigated the anti-SARS-CoV-2 post-vaccine response through serum and salivary
antibodies, serum antibody neutralizing activity and cellular immune response in samples …
antibodies, serum antibody neutralizing activity and cellular immune response in samples …
Vogt–Koyanagi–Harada disease after SARS‐CoV‐2 infection: Case report and literature review
H Zou, K Zhang, X Chen, S Sha - Immunity, Inflammation and …, 2024 - Wiley Online Library
Background Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is
responsible for coronavirus disease 2019 (COVID‐19), a complex and multifaceted illness …
responsible for coronavirus disease 2019 (COVID‐19), a complex and multifaceted illness …
Convalescent Adaptive Immunity Is Highly Heterogenous after SARS-CoV-2 Infection
B Pathakumari, PK Marty, M Shah… - Journal of Clinical …, 2023 - mdpi.com
The optimal detection strategies for effective convalescent immunity after SARS-CoV-2
infection and vaccination remain unclear. The objective of this study was to characterize …
infection and vaccination remain unclear. The objective of this study was to characterize …
Determination of prognostic markers for COVID-19 disease severity using routine blood tests and machine learning
TE Lima, MVF Ferraz, CAA Brito… - Anais da Academia …, 2024 - SciELO Brasil
The need for the identification of risk factors associated to COVID-19 disease severity
remains urgent. Patients' care and resource allocation can be potentially different and are …
remains urgent. Patients' care and resource allocation can be potentially different and are …
[HTML][HTML] Convalescent Adaptive Immunity is Highly Heterogenous after SARS-CoV-2 Infection
PK Marty, B Pathakumari, M Shah, VP Keulen… - Research …, 2023 - ncbi.nlm.nih.gov
Optimal detection strategies for effective convalescent immunity after SARS-CoV-2 infection
and vaccination remain unclear. The objective of this study was to characterize convalescent …
and vaccination remain unclear. The objective of this study was to characterize convalescent …
Vogt–Koyanagi–Harada Disease after SARS-CoV-2 Infection: Case Report
H Zou, K Zhang, X Chen, S Sha - Authorea Preprints, 2024 - advance.sagepub.com
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible
for coronavirus disease 2019 (COVID-19), a multifaceted condition. The COVID-19 is …
for coronavirus disease 2019 (COVID-19), a multifaceted condition. The COVID-19 is …